Anthrax

New Drug Fights Anthrax Toxin

Raxibacumab being stockpiled for possible anthrax attack, researcher says,, WEDNESDAY, July 8 (HealthDay News) -- Scientists report that experiments in animals show that a new, monoclonal antibody drug might safely cure anthrax poisoning in humans. Although antibiotics can kill the ...

Revisiting the anthrax attacks

PITTSBURGH, Jan. 22 When anthrax was sent through the U.S. Postal Service in 2001, an overwhelming majority of postal workers elected not to be inoculated with the available vaccine because of confusion and distrust, according to a University of Pittsburgh Graduate School of Public Health study. ...

Researchers Pursuing Nasal Anthrax Vaccine

Mice given combination version of immunization survived exposure, study reports,,,, THURSDAY, April 10 (HealthDay News) -- American researchers have developed a nasal spray anthrax vaccine that provides protection against the potentially deadly bacterium, at least in mice. By "deto...

Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine

- Grant to Cover Formulation Work, Stability Characterization of Dry-Patch Vaccine - GAITHERSBURG, Md., April 8, 2008 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) today announced it will receive a cost-reimbursement grant for up to $943,856 from the...

Key Anthrax Virulence Factor Discovered

Bacterial nitric oxide protects pathogen from immune system attacks THURSDAY, Jan. 24 (HealthDay News) -- Researchers have discovered how the anthrax bacterium protects itself from the immune system's biochemical assault. The results reveal not only a novel aspect of anthrax virule...

PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)

ANNAPOLIS, Md. and PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, and Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, today announced that...

Nasal Anthrax Vaccine Proves Effective in Animal Study

Though not ready for humans, it offered immunity for at least 6 months FRIDAY, Aug. 31 (HealthDay News) -- An experimental nasal anthrax vaccine proved highly effective in tests in mice and guinea pigs, a University of Michigan Medical School study shows. After it was placed inside the animal...

Eleven People Hospitalized in South Africa After Anthrax Scare

Eleven people were admitted to hospital in South Africa on Friday after they came into contact with an envelope suspected to contain anthrax powder, police said. Inspector Juanita Kilian said police had received a complaint from the post office in the district of Alberton, south of Johanne...

Orissa Under Anthrax Threat

Bhubaneswar, June 1 (IANS) Two people in Orissa's Koraput district have died of anthrax, a fairly uncommon disease while many people have been infected by the virus, health officials said Friday. Bisu Sisa, 45 and Nanda Jani, 35, of Koraput district, nearly 500 km from state capital Bhuban...

Physicists Unite To Develop Anthrax Detection Method

Physicists have joined forces to perfect a powerful new weapon in the war on terrorism – a laser technique to identify deadly anthrax spores. //Their results are published in the prestigious journal Science, due to hit newsstands tomorrow. “Our report shows how to use lasers to detect anthrax ...

More>>

Anthrax in Medical Technology

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

ANNAPOLIS, Md., April 28 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it will be hosting a conference call for investors on Wednesday, April 29th beginning at ...

Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study

- Anthim Dramatically Improves Survival in Animals with Clinical Symptoms of Anthrax disease - PINE BROOK, N.J., April 20 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatenin...

Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile

- Delivery of 20,000 doses of ABthrax will bring at least $150 million in revenue to HGS - ROCKVILLE, Md., Feb. 2 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced that it has begun delivery of 20,000 doses of its human monoclonal antibody drug ABthrax(TM...

New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies

- Human Genome Sciences' ABthrax(TM) shows lifesaving potential - - HGS on track to deliver 20,000 doses to Strategic National Stockpile beginning in 2008 - ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today annou...

Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic

PINE BROOK, N.J., Sept. 25 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, today announced it has been awarded a contract for $12 million for advanced d...

Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents

CHICAGO, Aug. 21 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), today announced the commencement of its collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), the lead governmental institute supporting biodefense research, under...

Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection

Pilot Study Demonstrates 50% Survival in Valortim-Treated Animals PRINCETON, N.J. and ANNAPOLIS, Md., March 29, 2007 /PRNewswire-FirstCall/ -- Medarex, Inc. , a leading monoclonal antibody company, and PharmAthene, Inc., a privately held biotechnology company dedicated to the development...

Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection

Pilot Study Demonstrates 50% Survival in Valortim-Treated Animals PRINCETON, N.J. and ANNAPOLIS, MD., March 29, 2007 - Medarex, Inc. (Nasdaq: MEDX), a leading monoclonal antibody company, and PharmAthene, Inc., a privately held biotechnology company dedicated to the development of biodefense cou...

Cethromycin Shown Effective Against Anthrax in Study

Advanced Life Sciences Achieves Key Endpoint in Primate Study CHICAGO, May 02, 2007 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection. This conclus...

Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax

Single-Dose Protection Observed Prior to or Up to 24 Hours After Exposure to Anthrax TORONTO, Ontario, May 24, 2007 /PRNewswire/ -- Targanta Therapeutics Corporation announced today the results from a recent study demonstrating oritavancin as a potential therapy for treating exposure to Bacillus a...

Anthrax in Medical Products

GeneXpert System

Description:... to deliver results. The GeneXpert module forms the core of the Biohazard Detection System deployed nationwide by the United States Postal Service for anthrax testing in mail sorting facilities. An expanded menu of tests is currently in development....
Company:Cepheid

Anthrax in Medical Definition

Anthrax Vaccine Immunization Program

... The anthrax Vaccine Immunization Program (AVIP), is the name o...ilitary and specific civilian personnel with the anthrax vaccine . It began in earnest in 1997 by the Clin...John Payhurst administers the first in a series of anthrax vaccinations to one of 6,200 sailors aboard the ai...

Artificial induction of immunity

...anisms cause specific diseases, Pasteur isolated the infectious agent from anthrax . He then derived a vaccine by altering the infectious agent so as to make ...ed, and thus was the first person successfully vaccinated against rabies. anthrax is now known to be caused by a bacterium , and rabies is known to be cause...

Anthrax in Medical Dictionary

Anthrax

Anthrax is an acute disease caused by Bacillus anthracis. It affects both humans and animals and most forms of the disease are highly lethal. There are effective vaccines against anthrax , and some forms of the disease respond... Anthrax is an American heavy metal band from New Yor...

Inhalation anthrax

Anthrax is an acute disease caused by Bacillus anthracis. It affects both humans and animals and most forms of the disease are highly lethal. There are effective vaccines against anthrax , and some forms of the disease respond... Inhalation (or respiratory) anthrax is an infectio...

Cutaneous anthrax

Anthrax is an acute disease caused by Bacillus anthracis. It affects both humans and animals and most forms of the disease are highly lethal. There are effective vaccines against anthrax , and some forms of the disease respond... Cutaneous anthrax is an infection of the skin ...

Vaccine

...of oral live rotavirus vaccine to all infants at ... Learn about anthrax disease and anthrax vaccine . Get information about vaccine risks and benefits. ... The va...

Spores

...k on designing life with ever more complexity. anthrax disease begins when spores of Bacillus anthracis invade an ... When inhaled, anthrax spores germinate and grow in the lymph nodes ...se spores , each of which can develop into a new anthrax bacterial cell, are ... Spores may survive in...

Rigor Mortis

...isambiguation) ... Rigor Mortis Similar Artists: Gorefest , Fleshcrawl , Slayer , Metallica , Megadeth , Cannibal Corpse , Atrophy , Atheist , anthrax Genres: Rock Learn what rigor mortis is and why it happens. ... Rigor mortis can be used to help estimate time of death. The onset of rig...

Eschar

...tized, the eschar turns darker. ... An enlarging, painless lesion with eschar surrounded by edema, usually on the ... See figure Cutaneous anthrax Ulcer With Black Eschar . Background | Back to top ... Eschar is dead tissue that sheds from healthy skin. It is caused by a burn or cauter...

Cutaneous

...ishmania that may cause... How is cutaneous anthrax spread? • What are the different types of anthrax disease? ... Cutaneous anthrax is a treatable skin infection that occurs whe...

Bacillus anthracis

... or anaerobic conditions. It is the only... anthrax is an acute disease caused by Bacillus anthra... is Bacillus anthracis . ... "The disease anthrax is caused by the bacteria Bacillus anthracis ...ection is Bacillus . anthracis spores. ... anthrax is an acute infectious disease caused by the s...

Antibiotic Resistance

...ment of resistance to drugs commonly used to treat malaria is of ... available drugs, thus raising the spectre of a post- antibiotic era. ... anthrax scares lead to overuse of antibiotics , resistance is feared ... pump the antibiotic from the cell. Mechanisms of resistance ... Resista...

Anthrax in Biological News

Early detection and quick response are key to defense against anthrax attack

NEW YORK (July 24, 2009) -- A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics. A new study finds that in order for a response to be effective, quick detection and treatment are essentia...

Novel handheld device detects anthrax with outstanding accuracy and reliability

Baltimore, MD, and Christchurch, NZ June 25, 2009 Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker (...

New technique used to profile anthrax genome

Scientists at the Georgia Institute of Technology have used a new approach, known as RNA-Seq, to profile the gene expression of the bacterium that causes anthrax, Bacillus anthracis. Their study, published March 20, 2009, online by the Journal of Bacteriology , marks the first time any bacterial...

FBI unveils science of anthrax investigation

They have worked for almost seven years in secret. Most people did not know that the work in Ray Goehner's materials characterization department at Sandia National Laboratories was contributing important information to the FBI's investigation of letters containing bacillus anthracis, the spores...

NIST, Army researchers pave the way for anthrax spore standards

Researchers from the National Institute of Standards and Technology (NIST) and the U.S. Army Dugway (Utah) Proving Ground have developed reliable methods based on DNA analysis to assess the concentration and viability of anthrax spores after prolonged storage. The techniques and data are essential...

New decontamination system kills anthrax rapidly without lingering effects

In October 2001, letters containing anthrax spores were mailed to several news media offices and two U.S. senators, killing five people and infecting 17 others. Clearing the Senate office building of the spores with chlorine dioxide gas cost $27 million, according to the Government Accountability ...

Team IDs weakness in anthrax bacteria

CAMBRIDGE, Mass.--MIT and New York University researchers have identified a weakness in the defenses of the anthrax bacterium that could be exploited to produce new antibiotics. The researchers found that nitric oxide (NO) is a critical part of Bacillus anthracis's defense against the immune re...

Using carbon nanotubes to seek and destroy anthrax toxin and other harmful proteins

Troy, N.Y. Researchers at Rensselaer Polytechnic Institute have developed a new way to seek out specific proteins, including dangerous proteins such as anthrax toxin, and render them harmless using nothing but light. The technique lends itself to the creation of new antibacterial and antimicrobia...

Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax

ROCKVILLE, Maryland July 9, 2009 Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacum...

Newly discovered protein kills anthrax bacteria by exploding their cell walls

Not all biological weapons are created equal. They are separated into categories A through C, category A biological agents being the scariest: They are easy to spread, kill effectively and call for special actions by the pubic health system. One of these worrisome organisms is anthrax, which has al...

More>>

Anthrax in Biological Technology

Novel method predicts impact of a covert anthrax release

A new statistical method that can estimate the origin and time of an aerosolized release of the pathogen causing anthrax, following detection of the first few cases has been developed by researchers from the Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling at Imperial Coll...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company's propos...

Novel handheld device detects anthrax with outstanding accuracy and reliability

Baltimore, MD, and Christchurch, NZ June 25, 2009 Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker (...

Independent U.S. Study Confirms Veritide's Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability

--In Testing Conducted by a U.S. Research Institute, Ceeker Correctly Detected Anthrax 100% of the Time-- --Provides First Responders with a Simple and Reliable Tool to Help Quickly Distinguish Public Health Emergencies from Mere Nuisances-- --Study Data to be Presented by Prof. Lou Rei...

Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study

CHICAGO, June 23 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced that a second non-human primate study involving its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day course of Restanza achieved a 100% su...

Novel method predicts impact of a covert anthrax release

A new statistical method that can estimate the origin and time of an aerosolized release of the pathogen causing anthrax, following detection of the first few cases has been developed by researchers from the Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling at Imperial Coll...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase II study of SparVax(TM) were presented yesterday at the 12th Annual Conf...

New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague

HUBBARD, Ohio, April 13 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX) a biotechnology company, is pleased to provide the following information: An independent study has found that NanoLogix's BNP(TM) Ultra-Fast Identification Technology allows the viewing of anthrax cultures fo...

Novel method predicts impact of a covert anthrax release

A new statistical method that can estimate the origin and time of an aerosolized release of the pathogen causing anthrax, following detection of the first few cases has been developed by researchers from the Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling at Imperial Coll...

PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting

ANNAPOLIS, Md., Feb. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Alternext US: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a Phase II study of SparVax(TM) and pharmacokinetic (PK) data for Valorti...

Anthrax in Biological Definition

Louis Pasteur

... caused the disease. In the 1870s he applied this immunization method to anthrax , which affected cattle , and aroused interest in combating other diseases...l smallpox material in inoculation. The difference with chicken cholera and anthrax was that the weakened form of the disease organism had been generated arti...

Robert Koch

...ir Davaine showed the direct transmission of the anthrax bacillus between cows, Koch studied anthrax more closely. He invented methods to purify the b...hile it could not survive outside a host for long, anthrax built persisting spores that could last a long tim...

Anthrax in Biological Dictionary

Vaccine

... development and distribution of preventive AIDS vaccines . Learn about anthrax disease and anthrax vaccine . Get information about vaccine risks and benefits. ... The vac...

Antibiotic resistance

...lopment of resistance to drugs commonly used to treat malaria is of ... available drugs, thus raising the spectre of a post- antibiotic era. ... anthrax scares lead to overuse of antibiotics , resistance is feared ... pump the antibiotic from the cell. Mechanisms of resistance ... Resistance...